Changes in the extensiveness of initial debulking surgery with increasing neoadjuvant chemotherapy use in advanced ovarian cancer: a nationwide population-based study
Journal of Gynecologic Oncology · 2027 · 38
DOI: 10.3802/jgo.2027.38.e9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2027. Verfasst von Junhwan Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.
- Division of Clinical Research, Research Institute, National Cancer Center, Goyang, Korea.
- Division of Clinical Research, Research Institute, National Cancer Center, Goyang, Korea. sokbom@ncc.re.kr.
ORCID-Profile: Junhwan Kim, Byeong-Chan Oh, Sokbom Kang
Förderung
- National Cancer Center
Zitieren
APA
Kim, J., Oh, B. C., & Kang, S. (2027). Changes in the extensiveness of initial debulking surgery with increasing neoadjuvant chemotherapy use in advanced ovarian cancer: a nationwide population-based study. Journal of Gynecologic Oncology, 38. https://doi.org/10.3802/jgo.2027.38.e9
Vancouver
Kim J, Oh BC, Kang S. Changes in the extensiveness of initial debulking surgery with increasing neoadjuvant chemotherapy use in advanced ovarian cancer: a nationwide population-based study. Journal of Gynecologic Oncology. 2027;38. doi:10.3802/jgo.2027.38.e9
BibTeX
@article{Kim2027,
author = {Kim, Junhwan and Oh, Byeong-Chan and Kang, Sokbom},
title = {Changes in the extensiveness of initial debulking surgery with increasing neoadjuvant chemotherapy use in advanced ovarian cancer: a nationwide population-based study},
journal = {Journal of Gynecologic Oncology},
year = {2027},
volume = {38},
doi = {10.3802/jgo.2027.38.e9}
}
EUVIMED